» Articles » PMID: 9291323

Antileukoprotease: an Endogenous Protein in the Innate Mucosal Defense Against Fungi

Overview
Journal J Infect Dis
Date 1997 Sep 18
PMID 9291323
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have suggested that endogenous protease inhibitors may participate in the mucosal host defense. Antileukoprotease (ALP) is an important protease inhibitor found on various mucosal surfaces, including those of the respiratory and genital tracts. This study reports on the antimicrobial activity of recombinant (r) ALP toward the human fungal pathogens Aspergillus fumigatus and Candida albicans. rALP expressed pronounced fungicidal activity toward metabolically active A. fumigatus conidia and C. albicans yeast cells; however, metabolically quiescent A. fumigatus conidia were totally resistant. In contrast with the protease inhibitory activity of rALP, the fungicidal activity was localized primarily in the NH2-terminal domain. On a molar base, the fungicidal activity of rALP was comparable with that of human defensins and lysozyme. In addition, rALP caused inhibition of C. albicans yeast cell growth. By exhibiting antifungal activity, ALP may play an important role in the innate mucosal defense against human pathogenic fungi.

Citing Articles

Salivary proteins modulate Candida albicans virulence and may prevent oropharingeal candidiasis.

Curvelo J, Barreto A, Bayona-Pacheco B, de Moraes D, Portela M, Ferreira-Pereira A Braz J Microbiol. 2024; 55(4):3811-3825.

PMID: 39320637 PMC: 11711915. DOI: 10.1007/s42770-024-01517-5.


Neonatal and maternal upregulation of antileukoproteinase in horses.

Holmes C, Babasyan S, Wagner B Front Immunol. 2024; 15:1395030.

PMID: 38736885 PMC: 11082313. DOI: 10.3389/fimmu.2024.1395030.


Secretory Leucoprotease Inhibitor (SLPI) Promotes Survival during Acute Infection by Suppression of Inflammation Rather Than Microbial Killing.

Osbourn M, Rodgers A, Dubois A, Small D, Humphries F, Delagic N Biomolecules. 2022; 12(12).

PMID: 36551159 PMC: 9776001. DOI: 10.3390/biom12121728.


Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.

Nugteren S, Simons-Oosterhuis Y, Menckeberg C, Hulleman-van Haaften D, Lindenbergh-Kortleve D, Samsom J Eur J Immunol. 2022; 53(2):e2249964.

PMID: 36480463 PMC: 10107746. DOI: 10.1002/eji.202249964.


The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis.

Knudsen K, Lehmann S, Nielsen R, Tangedal S, Paytuvi-Gallart A, Sanseverino W Microbiome. 2022; 10(1):175.

PMID: 36258251 PMC: 9580159. DOI: 10.1186/s40168-022-01362-4.